Chris Cline
Patrimonio netto: 6 M $ in data 31/05/2026
Patrimonio netto: 6 M $ in data 31/05/2026
Chris Cline currently works at National Investor Relations Institute, as Member and Travere Therapeutics, Inc., as Chief Financial Officer from 2022.
Mr. Cline also formerly worked at Elan Corp.
Plc, as Member from 2012 to 2014 and Phase Forward, Inc., as Head-Financial Planning.
Mr. Cline received his undergraduate degree from Williams College of Business.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 06/05/2026 | 118.658 ( 0,13% ) | 6 M $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| TRAVERE THERAPEUTICS, INC. | Direttore Finanziario/CFO | 31/08/2022 |
National Investor Relations Institute
National Investor Relations Institute Miscellaneous Commercial ServicesCommercial Services Operates as a association for corporate officers and investors | Corporate Officer/Principal | - |
| Società | Posizione | Fine |
|---|---|---|
Elan Corp. Plc
Elan Corp. Plc Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals and drug delivery systems | Corporate Officer/Principal | 01/02/2014 |
Phase Forward, Inc.
Phase Forward, Inc. Packaged SoftwareTechnology Services Develops e-process software solutions for accelerating global pharmaceutical development | Corporate Officer/Principal | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 5 |
|---|---|
Elan Corp. Plc
Elan Corp. Plc Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals and drug delivery systems | Health Technology |
Phase Forward, Inc.
Phase Forward, Inc. Packaged SoftwareTechnology Services Develops e-process software solutions for accelerating global pharmaceutical development | Technology Services |
National Investor Relations Institute
National Investor Relations Institute Miscellaneous Commercial ServicesCommercial Services Operates as a association for corporate officers and investors | Commercial Services |
Travere Therapeutics, Inc.
Travere Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that engages in developing and delivering life-changing therapies to people living with rare kidney, liver & metabolic diseases | Health Technology |
Williams College of Business
Williams College of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale